Item 8.01 Other Events.

On July 21, 2021, Organicell issued a press release in which it announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its lead product, Zofin™, for the treatment of 'Prolonged COVID-19 Symptoms' ("Long Haulers").

A copy of the Company's press release dated July 21, 2021 is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits






(d) Exhibits



Exhibit No   Description

   99.1        Press Release, dated July 21, 2021




                                       1

© Edgar Online, source Glimpses